WallStSmart
KOD

Kodiak Sciences Inc

NASDAQ: KOD · HEALTHCARE · BIOTECHNOLOGY

$39.85
-9.10% today

Updated 2026-06-05

Market cap
$2.13B
P/E ratio
P/S ratio
EPS (TTM)
$-4.17
Dividend yield
52W range
$3 – $48
Volume
0.7M

Kodiak Sciences Inc (KOD) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2016201720182019202020212022202320242025
Total assets$12.11M$3.24M$92.19M$358.87M$1.07B$904.22M$666.63M$479.37M$335.58M$351.53M
Cash & equivalents$9.62M$1.40M$88.25M$211.80M$944.40M$731.51M$190.43M$285.51M$168.07M$209.86M
Current assets$10.19M$1.59M$90.45M$339.23M$972.00M$734.81M$486.00M$289.31M$171.94M$214.82M
Total liabilities$53.20M$71.98M$5.36M$13.51M$206.60M$240.90M$230.46M$213.59M$185.29M$194.15M
Current liabilities$2.51M$9.16M$4.83M$11.71M$31.42M$64.68M$52.50M$41.73M$25.57M$45.53M
Long-term debt$103000.00$9.92M
Shareholder equity$-41.08M$-68.74M$86.83M$345.36M$860.75M$663.32M$436.17M$265.78M$150.29M$157.38M
Retained earnings$-41.39M$-69.32M$-110.77M$-158.13M$-291.23M$-558.22M$-892.04M$-1.15B$-1.33B$-1.56B
Accounts receivable
Inventory
Goodwill

Frequently asked questions

How much free cash flow does KOD generate?

KOD produced $-136.51M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is KOD's balance sheet healthy?

KOD holds $209.86M in cash and equivalents against — in long-term debt, on $157.38M of shareholder equity. That debt is best read against the cash flow the business throws off each year.